208 related articles for article (PubMed ID: 32522926)
41. The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis.
Tokuhira M; Tabayashi T; Tanaka Y; Takahashi Y; Kimura Y; Tomikawa T; Anan-Nemoto T; Momose S; Higashi M; Okuyama A; Watanabe R; Amano K; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2017; 56(3):165-169. PubMed ID: 28331131
[TBL] [Abstract][Full Text] [Related]
42. PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders.
Gion Y; Doi M; Nishimura Y; Ikeda T; Filiz Nishimura M; Sakamoto M; Egusa Y; Nishikori A; Fujita A; Iwaki N; Nakamura N; Yoshino T; Sato Y
Cancer Med; 2022 Jan; 11(2):417-432. PubMed ID: 34842351
[TBL] [Abstract][Full Text] [Related]
43. [Early onset of methotrexate-associated lymphoproliferative disorder mimicking Hodgkin's lymphoma].
Burg MR; Schneider SW
Hautarzt; 2022 Jan; 73(1):71-74. PubMed ID: 33796880
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type.
Kohno K; Suzuki Y; Elsayed AA; Sakakibara A; Takahara T; Satou A; Kato S; Nakamura S; Asano N
Am J Clin Pathol; 2020 Apr; 153(5):571-582. PubMed ID: 31977037
[TBL] [Abstract][Full Text] [Related]
45. Methotrexate-Related Lymphoproliferative Disorder in Patients With Osteonecrosis of the Jaw: A 3-Case Report and Literature Review.
Furudate K; Satake A; Narita N; Kobayashi W
J Oral Maxillofac Surg; 2018 Jan; 76(1):97-111. PubMed ID: 28654766
[TBL] [Abstract][Full Text] [Related]
46. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression.
Takanashi S; Aisa Y; Ito C; Arakaki H; Osada Y; Amano Y; Hirano M; Nakazato T
Rheumatol Int; 2017 Oct; 37(10):1629-1633. PubMed ID: 28676912
[TBL] [Abstract][Full Text] [Related]
47. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
Kameda T; Dobashi H; Miyatake N; Inoo M; Onishi I; Kurata N; Mitsunaka H; Kawakami K; Fukumoto T; Susaki K; Izumikawa M; Nakashima S; Shimada H; Takeuchi Y; Haba R; Mano S; Onishi H; Imataki O; Matsunaga T
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1302-9. PubMed ID: 24515570
[TBL] [Abstract][Full Text] [Related]
48. Large ulceration of the oropharynx induced by methotrexate-associated lymphoproliferative disorders.
Hanakawa H; Orita Y; Sato Y; Uno K; Nishizaki K; Yoshino T
Acta Med Okayama; 2013; 67(4):265-9. PubMed ID: 23970326
[TBL] [Abstract][Full Text] [Related]
49. Hepatic methotrexate-associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature.
Ono R; Kumagae T; Uojima H; Teshima S; Kudo M; Kitagawa I; Yoshizawa M
J Med Case Rep; 2019 Jun; 13(1):196. PubMed ID: 31242930
[TBL] [Abstract][Full Text] [Related]
50. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
Yamakawa N; Fujimoto M; Kawabata D; Terao C; Nishikori M; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Ohmura K; Fujii T; Kitano T; Kondo T; Yurugi K; Miura Y; Maekawa T; Saji H; Takaori-Kondo A; Matsuda F; Haga H; Mimori T
J Rheumatol; 2014 Feb; 41(2):293-9. PubMed ID: 24334644
[TBL] [Abstract][Full Text] [Related]
51. Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis.
Kikuchi J; Kaneko Y; Kasahara H; Emoto K; Kubo A; Okamoto S; Takeuchi T
Intern Med; 2016; 55(12):1661-5. PubMed ID: 27301524
[TBL] [Abstract][Full Text] [Related]
52. A case of acute diffuse large B cell lymphoma in an anti-human T-cell leukaemia virus type 1-positive rheumatoid arthritis patient treated with methotrexate, who died.
Yoshida N; Sugiyama G; Sugi S; Satake K; Wakasugi D; Yamasaki S; Mihara Y; Matsuda K; Ida H; Ohshima K; Yamaguchi R; Nakashima M
Mod Rheumatol Case Rep; 2020 Jul; 4(2):161-167. PubMed ID: 33087004
[TBL] [Abstract][Full Text] [Related]
53. Methotrexate-Associated Lymphoproliferative Disorders Mimicking Granulomatosis With Polyangiitis: A Radiological Diagnostic Challenge.
Tachibana T; Sasaki T; Wani Y; Komatsubara Y; Kuroda K; Naoi Y; Gion Y; Orita Y; Nishizaki K; Sato Y
Ear Nose Throat J; 2022 Sep; 101(8):NP362-NP366. PubMed ID: 33155857
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders.
Tokuhira M; Saito S; Suzuki K; Higashi M; Momose S; Shimizu T; Mori T; Kimura Y; Amano K; Okamoto S; Takeuchi T; Tamaru JI; Kizaki M
Leuk Lymphoma; 2019 Oct; 60(10):2508-2515. PubMed ID: 30947579
[TBL] [Abstract][Full Text] [Related]
55. Lymphoproliferative disorder with pathological fracture of the femur in a patient with rheumatoid arthritis treated with methotrexate: A case report.
Oebisu N; Hoshi M; Ieguchi M; Iwai T; Tanaka S; Osawa M; Nakamura H
Mol Clin Oncol; 2018 Aug; 9(2):187-191. PubMed ID: 30101019
[TBL] [Abstract][Full Text] [Related]
56. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
[TBL] [Abstract][Full Text] [Related]
57. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.
Tokuhira M; Tanaka Y; Takahashi Y; Kimura Y; Tomikawa T; Anan T; Watanabe J; Sagawa M; Higashi M; Momose S; Amano K; Tabayashi T; Nakaseko R; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2020 Jun; 60(2):41-50. PubMed ID: 32404570
[TBL] [Abstract][Full Text] [Related]
58. Intracranial Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis.
Miyaza S; Matsuda R; Nakamura M; Nakagawa I; Motoyama Y; Nakase H
World Neurosurg; 2019 Oct; 130():138-141. PubMed ID: 31295614
[TBL] [Abstract][Full Text] [Related]
59. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.
Saito S; Kaneko Y; Yamaoka K; Tokuhira M; Takeuchi T
Rheumatology (Oxford); 2017 Jun; 56(6):940-946. PubMed ID: 28165538
[TBL] [Abstract][Full Text] [Related]
60. Macrophage activation syndrome triggered by methotrexate-related lymphoproliferative disease in a patient with rheumatoid arthritis.
Kato H; Suzuki M; Misumi K; Kohsaka H
Immunol Med; 2023 Dec; 46(4):191-195. PubMed ID: 37199221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
